Related references
Note: Only part of the references are listed.Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
G. Nishikawa et al.
BRITISH JOURNAL OF CANCER (2013)
KRAS and GNAS Mutations and p53 Overexpression in Biliary Intraepithelial Neoplasia and Intrahepatic Cholangiocarcinomas
Maylee Hsu et al.
CANCER (2013)
Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct
Motoko Sasaki et al.
HISTOPATHOLOGY (2013)
Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum
Akiko Matsubara et al.
JOURNAL OF PATHOLOGY (2013)
Lamellar Structures of MUC2-Rich Mucin: A Potential Role in Governing the Barrier and Lubricating Functions of Intestinal Mucus
Andrew N. Round et al.
BIOMACROMOLECULES (2012)
Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia
Mitsuro Kanda et al.
GASTROENTEROLOGY (2012)
Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
Flavio G. Rocha et al.
HEPATOLOGY (2012)
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
Jean Charles Nault et al.
JOURNAL OF HEPATOLOGY (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct
Hanno Matthaei et al.
HPB (2012)
Similarities and Differences Between Intraductal Papillary Tumors of the Bile Duct With and Without Macroscopically Visible Mucin Secretion
Masayuki Ohtsuka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Jian Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas
Toru Furukawa et al.
SCIENTIFIC REPORTS (2011)
A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: Is the biliary tract an incomplete pancreas?
Yasuni Nakanuma
PATHOLOGY INTERNATIONAL (2010)
Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis
M. Sasaki et al.
JOURNAL OF PATHOLOGY (2008)
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors:: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission
Pamela U. Freda et al.
PITUITARY (2007)
The isolated MUC5AC gene product from human ocular mucin displays intramolecular conformational heterogeneity
Andrew N. Round et al.
GLYCOBIOLOGY (2007)
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis
A Ishikawa et al.
LABORATORY INVESTIGATION (2004)
Pathologic features of mucin-producing bile duct tumors - Two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms
H Shibahara et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract
SC Abraham et al.
HUMAN PATHOLOGY (2003)
Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas
HJ Kim et al.
ENDOSCOPY (2000)
Share Paper
